docetaxel,darolutamide
bayer
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'docetaxel', 'arasens', 'darolutamide']
arasens trial: the combination of darolutamide + adt + docetaxel improved overall survival. the risk of death was reduced by ~30% across volume and risk subgroups. mos was not reached in the darolutamide group regardless of volume or risk. #gu23 #prostatecancer 
Jefe de Servicio de Oncología Médica. Hospital Universitario Lucus Augusti, HULA. Grupo de Investigación Oncológica Traslacional, GIOT HULA. Cuenta personal